This will play a video - Two male physicians and one female nurse talk by a desk in a hospital hallway.

DETECT EARLY. TREAT EARLY.

Join Medtronic in leading a proactive approach to GI care.

LET’S MAKE A DIFFERENCE

Together, we can attract and retain more patients with gastrointestinal and hepatological diseases and cancers — making a difference in your practice and in your patients’ lives.

Older male physician shakes hands with female patient while nurse in magenta scrubs stands nearby

Portrait of male physican in white coat with stethoscope around his neck and hospital hallway blurry in background

EMPOWERING CONFIDENCE

Our solutions provide actionable diagnostic results and reliable treatments to help you optimize your clinical approach for your patients — no matter how complex.^1-17

PATIENT-FRIENDLY INNOVATION

We reduce barriers to care with minimally invasive solutions.

COMMITTED TO PARTNERSHIP

We make it our business to support yours, with partnership that goes beyond our products.

REDUCING DISEASE PROGRESSION

We strive to provide diagnostics and treatment options that are efficient and cost effective.

Lacy et al. Clinical utility of the wireless pH capsule. J Clin Gastroenterol 2011;45:429-435.

Sweis et al. Prolonged, wireless pH studies have a high diagnostic yield in patients with reflux symptoms and negative 24hr catheter-based pH studies. Neurogastro Motil 2011; 23(5): 419-26.

Richter et al. Utilization of wireless pH monitoring technologies: a summary of the proceedings from the Esophageal Diagnostic Working Group. Diseases of the Esophagus 2013; 26(8): 755-65.

⁴

Vela MF, Diagnostic Work-Up of GERD. Gastrointest Clin N Am 2014;24(4):655-666.

⁵

Karamanolis G et al. Yield of combined Impedance – pH Monitoring for Refractory Reflux Symptoms in Clinical Practice. J Neurogastroenterol Motil 2011;17(2):158-163.

⁶

Mainie et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006;55:1398-1402.

⁷

Kawamura O et al. Evaluation of PPI-resistant NERD by ESO manometry and 24-hr ESO impendence and pH monitoring. Digestion 2015; 91:19-25.

⁸

Vaezi MF et al. ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol 2013;108(8):1238-1249.

⁹

Bansal et al. Has high-resolution manometry changed the approach to esophageal motility disorders? Curr Opin Gastroenterol 2010;26:344–351.

¹⁰

Lee et al. High resolution and high definition anorectal manometry and pressure topography diagnostic advance or a new kid on the block. Curr Gastroenterol Rep 2013; 15:360.

¹¹

Shaheen NJ, Sharma P, et al. Radiofrequency Ablation in Barrett's Esophagus with Dysplasia. New England Journal of Medicine 2009 May;360(22):2277-2288.

¹²

Phoa KY, van Vilsteren FG, Pouw RE, Bergman J et al. Radiofrequency Ablation vs Endoscopic Surveillance for Patients with Barrett Esophagus and Low-Grade Dysplasia A Randomized Clinical Trial. JAMA. 2014; 311(12):1-10.

¹³

Dionisio PM, Gurudu SR, Leighton JA, et al. Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small-bowel Crohn's disease: a meta-analysis. Am J Gastroenterol. 2010;105(6):1240-1248.

¹⁴

Eliakim R, Yassin K, Niv Y, et al. Prospective multicenter performance evaluation of the second-generation colon capsule compared with colonscopy. Endoscopy. 2009; 41: 1026-1031; Spada C, Hassan C, Munoz-Navas M, et al. Second-generation colon capsule endoscopy compared with colonscopy. Gastrointestinal Endoscopy, 2011.

¹⁵

Bhardwaj A, Hollenbeak CS, Pooran N, et al. A meta-analysis of the diagnostic accuracy of esophageal capsule endoscopy for Barrett's esophagus in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2009 Jun;104(6):1533-9.

¹⁶

Sarosiek I, Selover KH, Katz LA, et al. The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology. Aliment Pharmacol Ther. 2010 Jan 15;31(2):313-22.

¹⁷